About Brad Sobolewski, MD, MEd

Brad Sobolewski, MD, MEd is a Professor of Pediatric Emergency Medicine and an Associate Director for the Pediatric Residency Training Program at Cincinnati Children's Hospital Medical Center. He is on Twitter/X @PEMTweets, on Instagram @BradSobolewski, authors the Pediatric Emergency Medicine site PEMBlog and is the host and creator of PEM Currents: The Pediatric Emergency Medicine Podcast. All views are strictly my own and not official medical advice.

Whoop! There It Is: A Pertinent Pediatric Pertussis Podcast

By |2024-12-03T15:38:27-05:00December 4th, 2024|Infectious Diseases, Podcasts|

This episode of PEM Currents: The Pediatric Emergency Medicine Podcast discusses pertussis, or whooping cough, a persistent public health issue despite vaccinations. Key topics include its clinical stages, management strategies, and the importance of infection control and vaccination. It emphasizes the role of healthcare providers in diagnosing, managing, and educating about pertussis to mitigate outbreaks.

A fabulous virtual education session on delivering and receiving feedback from the AAP Section on Emergency Medicine

By |2024-11-21T11:19:58-05:00November 21st, 2024|Education, PEMBlog Updates|

I am excited to share the recording of the AAP Section on Emergency Medicine Fall Virtual Education Session, originally held on Tuesday, November 19, 2024 focused on delivering timely and actionable feedback, along with strategies to develop and implement sustainable feedback programs.

Probiotics don’t improve outcomes in children with acute gastroenteritis

By |2024-10-31T10:15:17-04:00October 31st, 2024|Infectious Diseases|

Acute gastroenteritis affects millions of children in the U.S. every year, leading to emergency department visits and hospitalizations. Probiotics, particularly Lactobacillus rhamnosus GG (LGG), have been commonly used as a treatment, but evidence supporting their effectiveness has been limited. A new study conducted by the Pediatric Emergency Care Applied Research Network (PECARN) aimed to determine whether LGG could reduce the severity of gastroenteritis in children. The trial found that LGG did not significantly improve outcomes compared to placebo.

Go to Top